Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) - Pfaller, M A; Bassetti, M; Duncan, L R; Castanheira, M (J Antimicrob Chemother, 2017)